Clinical Trial Update: A Study to Quantify Bacille Calmette Guerin (BCG) and Characterise the Immune Response After BCG Vaccination [Phase 1]

View source ↗

Summary

Phase 1 study by the University of Oxford to quantify the immune response after Bacille Calmette-Guérin vaccination and characterize the immune profile, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED